Table 3.
Item | Groups | -- P -- | ||||
---|---|---|---|---|---|---|
Control | Sildenafil | Mucuna pruriens | Tribulus terrestris | Ashwagandha | ||
Total Motility,% | 75.00 ± 5.49bc | 80.00 ± 4.16b | 80.00 ± 4.16b | 84.29 ± 5.34a | 78.00 ± 5.37b | <0.05 |
Count * | 110.33 ± 37.78b | 146.29 ± 21.55a | 148.57 ± 31.45a | 161.42 ± 36.11a | 154.80 ± 10.55a | <0.05 |
Abnormal sperm rate, % | ||||||
Head | 5.00 ± 3.85 | 3.71 ± 2.56 | 4.43 ± 2.76 | 3.00 ± 1.53 | 5.40 ± 2.88 | >0.05 |
Tail | 5.17 ± 2.14 | 4.86 ± 1.35 | 5.00 ± 2.45 | 3.86 ± 1.68 | 7.40 ± 3.21 | >0.05 |
Total | 10.17 ± 4.71 | 8.57 ± 2.37 | 9.43 ± 3.82 | 6.86 ± 2.11 | 12.80 ± 5.31 | >0.05 |
Control, no treatment; Sildenafil, rats treated with Sildenafil (5 mg/kg/d); Mucuna, rats treated with Mucuna pruriens (300 mg/kg bw); Tribulus; rats treated with Tribulus terrestris (300 mg/kg bw); Ashwagandha; rats treated with Ashwagandha (300 mg/kg bw). Data are LS means ± SE (n = 7). Different superscripts in the same row (a–c) indicate group mean differences (p < 0.05). *Million/right cauda epididymis